Inhibiting Interleukin-4 and Interleukin-13 in Difficult-to-Control Asthma

被引：36

作者：

Wechsler, Michael E. ^{[1
]}

机构：

[1] Natl Jewish Hlth, Dept Med, Denver, CO USA

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2013年 / 368卷 / 26期

关键词：

EOSINOPHILIC ASTHMA; DOUBLE-BLIND; MEPOLIZUMAB; ANTAGONIST; EFFICACY; SAFETY; TRIAL;

D O I：

10.1056/NEJMe1305426

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2511 / 2513

页数：3

共 14 条

[1] A randomized, double-blind, placebo-controlled study of the CRTH2 antagonist OC000459 in moderate persistent asthma [J].

Barnes, N. ;

Pavord, I. ;

Chuchalin, A. ;

Bell, J. ;

Hunter, M. ;

Lewis, T. ;

Parker, D. ;

Payton, M. ;

Collins, L. Pearce ;

Pettipher, R. ;

Steiner, J. ;

Perkins, C. M. .

CLINICAL AND EXPERIMENTAL ALLERGY, 2012, 42 (01) :38-48

[2] Can guideline-defined asthma control be achieved? The gaining optimal asthma control study [J].

Bateman, ED ;

Boushey, HA ;

Bousquet, J ;

Busse, WW ;

Clark, TJH ;

Pauwels, RA ;

Pedersen, SE .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2004, 170 (08) :836-844

[3] The novel TLR-9 agonist QbG10 shows clinical efficacy in persistent allergic asthma [J].

Beeh, Kai-Michael ;

Kanniess, Frank ;

Wagner, Frank ;

Schilder, Cordula ;

Naudts, Ingomar ;

Hammann-Haenni, Anya ;

Willers, Joerg ;

Stocker, Hans ;

Mueller, Philipp ;

Bachmann, Martin F. ;

Renner, Wolfgang A. .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2013, 131 (03) :866-874

[4] Safety and efficacy of the prostaglandin D2 receptor antagonist AMG 853 in asthmatic patients [J].

Busse, William W. ;

Wenzel, Sally E. ;

Meltzer, Eli O. ;

Kerwin, Edward M. ;

Liu, Mark C. ;

Zhang, Nan ;

Chon, Yun ;

Budelsky, Alison L. ;

Lin, Joseph ;

Lin, Shao-Lee .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2013, 131 (02) :339-345

[5]

Busse WW, 2013, THORAX

[6] Reslizumab for Poorly Controlled, Eosinophilic Asthma A Randomized, Placebo-controlled Study [J].

Castro, Mario ;

Mathur, Sameer ;

Hargreave, Frederick ;

Boulet, Louis-Philippe ;

Xie, Fang ;

Young, James ;

Wilkins, H. Jeffrey ;

Henkel, Timothy ;

Nair, Parameswaran .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 184 (10) :1125-1132

[7] Mepolizumab and Exacerbations of Refractory Eosinophilic Asthma [J].

Haldar, Pranabashis ;

Brightling, Christopher E. ;

Hargadon, Beverley ;

Gupta, Sumit ;

Monteiro, William ;

Sousa, Ana ;

Marshall, Richard P. ;

Bradding, Peter ;

Green, Ruth H. ;

Wardlaw, Andrew J. ;

Pavord, Ian D. .

NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (10) :973-984

[8] Masitinib, a c-kit/PDGF receptor tyrosine kinase inhibitor, improves disease control in severe corticosteroid-dependent asthmatics [J].

Humbert, M. ;

de Blay, F. ;

Garcia, G. ;

Prud'homme, A. ;

Leroyer, C. ;

Magnan, A. ;

Tunon-de-Lara, J. -M. ;

Pison, C. ;

Aubier, M. ;

Charpin, D. ;

Vachier, I. ;

Purohit, A. ;

Gineste, P. ;

Bader, T. ;

Moussy, A. ;

Hermine, O. ;

Chanez, P. .

ALLERGY, 2009, 64 (08) :1194-1201

[9] Tiotropium in Asthma Poorly Controlled with Standard Combination Therapy [J].

Kerstjens, Huib A. M. ;

Engel, Michael ;

Dahl, Ronald ;

Paggiaro, Pierluigi ;

Beck, Ekkehard ;

Vandewalker, Mark ;

Sigmund, Ralf ;

Seibold, Wolfgang ;

Moroni-Zentgraf, Petra ;

Bateman, Eric D. .

NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (13) :1198-1207

[10] Safety and efficacy of a CXCR2 antagonist in patients with severe asthma and sputum neutrophils: a randomized, placebo-controlled clinical trial [J].

Nair, P. ;

Gaga, M. ;

Zervas, E. ;

Alagha, K. ;

Hargreave, F. E. ;

O'Byrne, P. M. ;

Stryszak, P. ;

Gann, L. ;

Sadeh, J. ;

Chanez, P. .

CLINICAL AND EXPERIMENTAL ALLERGY, 2012, 42 (07) :1097-1103

← 1 2 →